Introduction
HSV-1 is a large (152 kb) enveloped, double-stranded DNA virus with a natural tropism for neurons where it establishes latency, a potentially life-long state in which the viral genome is maintained in an episomal structure in the absence of viral lytic gene expression. These attributes suggest that HSV may be modified to serve as a useful tool for gene transfer to the nervous system, but this potential may be limited by the cytotoxic properties of replication-incompetent mutant HSV-1 vectors. Following infection in permissive cell types HSV-1 expresses more than 80 viral genes in a well ordered cascade of immediate-early (IE), early (E) and late (L) gene products resulting in the production of progeny virus and cell lysis, usually within 24 h. Mutant viruses deleted for the sequences encoding the essential IE transcriptional transactivator ICP4 are severely impaired for expression of E and L gene products and do not produce infectious viral progeny but are, none the less, toxic to cells in culture. 1, 2 ICP4 mutant viral gene expression in cell culture is limited to IE genes ICP0, ICP22, ICP27 and ICP47 as well as the IE/E gene ICP6 and ORF P, 3, 4 suggesting that the toxicity of this mutant may result from the expression of one or more of these gene products. This conclusion is supported by the observations that: (1) UV irradiation of viral particles before infection substantially reduces viral gene expression and attendant toxicity without compromising the ability of the particle to enter cells, suggesting that viral gene expression is primarily responsible for the cytotoxicity of replication-defective viral mutants; 2 and (2) pretreatment of target cells with IFN-␣ reduces both transcription of viral IE genes and the toxicity of ICP4 − replication-incompetent virus. 2 Johnson et al have shown that of the gene products expressed in ICP4 − mutants, ICP0, ICP22 and ICP27, are toxic to CV-1 and BHK-TK − cells when expressed from transfected plasmid constructs. 5 More recently it has been reported that viruses simultaneously deleted for ICP4, ICP22 and ICP27 are reduced in cytotoxicity compared with viruses deleted for ICP4 alone or ICP4 in combination with ICP27. 6 It has also been reported that elimination of ICP4, ICP27, ICP22 and ICP0 renders the virus largely innocuous to cells at relatively high multiplicities of infection (MOI) indicating that expressed viral functions account for viral toxicity and that viral structural proteins play a minor role. 7 However, transgene expression was dramatically reduced in this mutant background 7 suggesting that some viral function (eg ICP0) may be required for efficient transduction. The cytotoxic properties and transgene expression profile of multiply deleted IE gene mutants have not been tested on neurons.
In order to compare directly the cytotoxic properties of the IE gene products ICP4, ICP22, ICP27 and ICP47 in mitotic cell lines and primary post-mitotic neurons in cul-ture, we generated mutant viruses deleted for various combinations of these IE genes and examined the effect of these deletions on the cytotoxicity of these mutant viruses following infection of Vero, 9L rat gliosarcoma and primary neuronal cells in culture. Recombinants deleted simultaneously for ICP4, ICP22 and ICP27 were substantially less toxic to cells in culture than replication-incompetent viruses deleted for ICP4 alone. In general agreement with an earlier report 6 we found that infection of Vero cells in culture with this multiple IE gene-deleted vector led to inhibition of cellular DNA synthesis and cellular replication. However, in contrast to reported findings, 6 these effects were found to be transient in Vero cells, ultimately permitting cell division and colony formation. Since the primary toxic effect appeared to be interference with DNA synthesis, we reasoned that these highly deleted mutant viruses may be less cytotoxic for post-mitotic cortical and dorsal root neurons in culture which survive even wild-type virus lytic gene expression before the establishment of latency in vivo. The results indicate that our triple mutant vectors were substantially less cytotoxic for primary neurons than single mutant vectors, demonstrating the capacity for efficient transduction and prolonged transgene expression in neurons.
Results

Construction of HSV-1-based viral mutants containing deletions in multiple immediate-early genes
We created a series of recombinant viral mutants deleted for various combinations of the HSV-1 IE genes ICP4, ICP22, ICP27 and ICP47. Single (S) IE gene mutants were deleted for ICP4 alone; double (D) mutants were deleted for ICP22 and ICP27 or ICP4 in combination with ICP22, ICP27 or ICP47; and triple (T) mutants were deleted for ICP4, ICP22 and ICP27 (Figure 1a and b) . Two T mutants, THZ.3 and TOZ.1, were further modified to include deletions in the late (L) U L 41 gene which encodes the tegument virion host shut-off protein (Figure 1c ). The effect of viral gene deletion on viral replication was tested on complementing and noncomplementing cell lines (Figure 1a) . None of the replication-defective viral mutants were able to replicate on noncomplementing Vero cells. Mutants defective in an essential IE gene, ICP4, ICP27, or both, require complementing cell lines which provide these gene products for viral replication in culture. N23 cells provide ICP27 in trans upon infection and supported the growth of the ICP22/ICP27-deleted virus (DHZ.3). E5 cells provide ICP4 in trans upon infection and supported the growth of mutants deleted for ICP4 alone, and ICP4 in combination with ICP22 (DHZ.1) and ICP47 (DHZ.2). 7B cells produce ICP4 and ICP27 upon infection and were required for propagation of T mutants (THZ.1, THZ.3 and TOZ.1) as well as the ICP4/ICP27 double mutant (DHZ.4).
Deletion of non-essential viral genes or interruption of viral genes by expression constructs may reduce the efficiency of viral growth in culture, leading to a reduction in attainable titers of viral stocks. We measured the titer of viral stocks of each mutant produced on ICP4/ICP27 complementing 7B cells. Viruses deleted for ICP4 alone (SHZ.1 and SHZ.2) grew to titers of 2 × 10 10 p.f.u. per 10 8 cells. This was true whether the viruses contained an HCMV IEp lacZ construct interrupting the viral thymidine kinase HSVtk (U L 23) coding sequence (SHZ.1), or contained HCMV IEp lacZ and a chimeric construct with the ICP4 IE promoter driving HSVtk interrupting the native HSVtk sequence (SHZ.2). However, viruses in which replacement of the tk promoter with an ICP4 promoter resulted in disruption of the viral sequences coding U L 24 grew to maximum titers that were reduced by one order of magnitude (S4TK compared with SHZ.2) ( Figure  1b) . The maximum titer of viral mutants containing a deletion in ICP22 (U S 1) was also reduced by one order of magnitude (DHZ.1 compared with S4TK) (Figure 1b) . The construction of ICP22 complementing cell lines has been difficult to achieve due to its high level toxicity. However, Samaniego et al 7 (Figure 2a) . DHZ.2 which was deleted for ICP4 and ICP47 including U S 10-11 demonstrated higher 3 H-thymidine incorporation than other viruses with two IE deletions at a MOI of 3, but was indistinguishable from other viruses with two IE gene deletions at higher MOI. When cell survival was measured by colony-forming assay, mutants deleted for two IE genes were less toxic than ICP4-deleted viruses alone, and mutants deleted for three IE genes allowed the formation of almost twice as many colonies at MOI of both 3 and 10 ( Figure 2b ). The only exception was the double mutant deleted for ICP4 and ICP27 (DHZ.4) which was as toxic as the single ICP4 mutant (SHZ.1) (Figure 2b ). The additional deletion of the U L 41 gene did not further reduce cytotoxicity of these mutants. H-thymidine were infected, duplicate cultures were treated with ganciclovir (GCV, 10 g/ml). HSVtk converts the nontoxic prodrug GCV into a defective nucleoside analogue resulting in chain termination during DNA synthesis with a concomitant reduction in DNA synthesis resulting in cell death. 7 GCV has been shown to affect cells beyond those in which it is modified by HSV-TK apparently through cell to cell transfer of the phosphorylated prodrug, a phenomenon known as the 'bystander effect'. 8 However, in this experiment these cells were plated far below confluence to prevent cell to cell transfer of activated GCV and limit possible reduction in 3 H-thymidine incorporation due to contact inhibition of cells during the measurement period. 8 In THZ.3, HSV-TK is driven by the ICP4 IE promoter and thus is expressed as an IE gene in this viral background. The addition of GCV to THZ.3-infected Vero cells resulted in an irreversible block in DNA synthesis, suggesting that the increased DNA synthesis observed in cells infected with THZ.3 did not occur in uninfected cells. In order to determine whether the inhibition of cellular DNA synthesis reflected the death of infected cells, we counted the number of viable cells from 24-120 h PI. Twenty-four hour PI with THZ.3 at an MOI of 3 or 10, no evidence of cell death was observed and viable cell numbers were not significantly different from the number of cells originally plated confirming that the reduction in DNA synthesis found in these cells is not due to cell death (Figure 3b and c) . At both MOI tested, infection with the THZ.3 mutant virus led to a reduction in cell division that lasted up to 48 h PI ( Figure  3c ). By 72 h PI viable cell numbers increased dramatically, reflecting DNA synthesis, which began at 36-48 h PI (Figure 3b 
Discussion
HSV efficiently infects and persists in neurons potentially providing an important vehicle for gene transfer to the nervous system. Despite the fact that even wild-type virus is able to establish latency in neurons of the peripheral nervous system without destruction of the host cells, highly defective, replication-incompetent HSV-1 mutants will readily kill neurons in cell culture thus limiting their usefulness for gene transfer studies in vitro and raising safety questions for in vivo applications. Mutants deleted for single essential IE genes are cytotoxic to neurons in culture even though they express only the remaining viral IE genes in substantial amounts. Here we demonstrate that replication-incompetent HSV-1 vectors deleted for three IE genes, ICP4, ICP22 and ICP27 are substantially reduced in cytotoxicity compared with replicationincompetent HSV vectors deleted for ICP4 alone or in combination with ICP27 or ICP22. Primary cortical and dorsal root ganglia neurons infected in culture with viruses deleted for all three genes survived over 21 days in culture following low multiplicity infection without obvious morphological change or cell death. Additionally, both the HSV-1 ICP0 IE or HCMV IE promoter remained active in this viral background for over 14 days after infection. The ability to infect neurons in culture efficiently without obvious damage or silencing of reporter gene expression suggests that multiply deleted HSV vectors may be useful for the study of gene expression in neurons. The development of HSV vectors for gene transfer to the nervous system in vivo has included replication competent and defective viruses. 11 The replication competent vectors are generally defective in genes that contribute to virus growth in brain neurons and included the ribonucleotide reductase, 12 ICP34.5 13 and the Us3 protein kinase.
14 Many of these genes affect the ability of the virus to replicate its DNA in post-mitotic neurons. These mutant viruses vary in their pathogenesis for the nervous system but all establish latency following limited virus spread. Replicating vectors have been used to inoculate the peripheral nervous system and following virus replication the virus establishes latency in sensory neurons. Reporter genes have been shown to be expressed for substantial time periods using the peripheral nervous system as a a b
Figure 6 X-gal staining of infected primary DRG cultures. (a) Staining at 1 (left), 2 (middle) and 4 (right) days PI demonstrates the reduced neuronal toxicity of TOZ.1 (bottom) compared with SOZ.1 (top). Notice the selective elimination of support cells in TOZ.1-infected cultures with sparing of neuronal cells. (b) Reduced toxicity of TOZ.1 allows transgene detection at 21 days PI.
reservoir for the latent vector. [15] [16] [17] In general, the use of replicating vectors has attractive features, especially for brain cancer therapy. 13 However, for most applications, particularly related to modifying brain functions, replicating vectors raise serious concerns over safety and the potential for reactivation of resident latent virus.
The generation of multiply deleted vectors provides safety benefits for potential applications in vivo. Using cell lines which provide both ICP4 and ICP27 in trans, these vectors can be grown to high titer (10 8 -10 9 p.f.u./ml) while offering a substantial reduction in the possible generation of replication-competent virus. Upon propagation of viruses deleted for ICP4 and ICP27 on permissive cell lines it has been estimated that replication-competent virus should arise at a frequency of less than 1 in 10 12 viral particles. In our studies replicationcompetent virus has not been isolated from stocks of this vector when propagated by low multiplicity infections. In addition to safety issues, these vectors have been designed for ease of transgene introduction. The triple IE gene-deleted vectors, THZ.3 and TOZ.1, contain unique PacI restriction sites flanking the lacZ reporter gene which allows rapid production of recombinant vectors using a procedure recently developed in this laboratory. 18 This recombination method has been used for the insertion of multiple expression cassettes into the genome at distinct locations allowing the generation of vectors capable of expressing multiple transgenes (up to five thus far) from a single vector. 19 Together our observations suggest that these triple IE gene-deleted vectors offer substantial improvement over previous HSV-1-based vectors used for gene transfer to neurons in terms of safety, cytotoxicity, efficiency of recombinant vector production, and duration of transgene expression.
Similar to effects seen in post-mitotic neurons, replication-incompetent HSV-1 vectors deleted for ICP4 alone are toxic to replicating cells. When cytotoxicity was measured either by inhibition of cellular DNA synthesis or cellular replication following infection in culture, mutants simultaneously deleted for ICP4, ICP22 and ICP27 were substantially less toxic than viruses deleted for ICP4 alone. Viruses deleted for two IE genes (DHZ. These results are in agreement with and extend the findings of Johnson et al 2, 5 who reported that reduction of IE gene expression in replication-incompetent HSV mutants results in a reduction in cytotoxicity. In those experiments IE gene expression reduced either by UV irradiation of virus stocks or pretreatment of target cells with IFN␣ before infection resulted in a reduction of cytopathic effects associated with viral infection, demonstrating a correlation between IE gene expression and cytotoxicity. In transfection assays they found that three of the six proteins expressed in substantial quantities following infection with ICP4
− viruses, the HSV-1 IE gene products ICP0, ICP22 and ICP27, were toxic to CV-1 and BHK TK − cells when expressed individually from plasmid constructs. 5 The toxicity of these gene products is due to their ability to interfere with host cell metabolism. ICP22 has been shown to be involved in modification of RNA polymerase II, while ICP27 has been found to alter polyadenylation site usage and disrupt cellular splicing machinery leading to reductions in cellular mRNAs following infection. [22] [23] [24] ICP0 is a promiscuous transactivator that induces expression of a number of cellular genes including the transcriptional transactivator AP-1, and has also been shown to associate with nuclear structures known as PODs resulting in redistribution of these structures. [25] [26] [27] [28] The individual contribution of each of these proteins to the development of cytotoxicity in infected cells is not known. However, the finding that expression of these genes even at basal levels, which would be expected from HSV IE promoters in the absence of transinduction, leads to a reduction in cell viability would suggest that deletion of these genes from an ICP4 null mutant would result in a vector reduced in cytotoxic effects. 25, 29 Indeed Samaniego et al 7 reported that the simultaneous deletion of ICP0, ICP4, ICP22 and ICP27 completely eliminated vector toxicity at relatively high multiplicity infections although transgene expression also rapidly declined.
Aside from the reduction in cytotoxicity resulting from the direct effects of individual viral gene deletions, deletion of IE genes (many of which serve gene regulatory functions) may reduce cytotoxicity through modifying expression of remaining IE genes. In mutants deleted for ICP4, ICP22 and ICP27 only ICP0, ICP6, ORF P and ICP47 expression is expected. Of these, only ICP0 has been shown to be toxic to cells in culture. 5 It has been shown that deletion of ICP22 results in reduced accumulation of ICP0 mRNA following infection possibly explaining the magnitude of reduction of cytotoxicity associated with deletion of ICP22 from an ICP4 − or ICP4
− mutant virus. 30 Wu et al 6 has shown that in Vero cells after infection with viruses deleted for ICP4, ICP22 and ICP27, ICP0 is expressed for up to 3 days and accumulates in the nucleus of infected cells where it is localized to dense spherical bodies. Coincident with the formation of these nuclear bodies was irreversible inhibition of DNA synthesis and cellular replication. 6 In our experiments, infection of Vero cells with viral mutants deleted for ICP4, ICP22 and ICP27 transiently inhibited cellular DNA synthesis and cell division for 36 h PI. These transient effects were viral dose dependent and may be related to levels of ICP0 in the infected cell since the period of perturbation coincides with the period of peak ICP0 expression in the cell. We found that the ICP0 promoter expresses at high levels for 2 d PI, reflecting transinduction of the promoter by VP16, a tegument protein which functions as a transcriptional transactivator of HSV IE genes, after which ICP0 promoter activity decreases to a basal level and continues for up to 21 days in culture. It is possible that accumulation of ICP0 in the nucleus of infected cells may block DNA synthesis and cell division until the time that ICP0 expression declines below a threshold level, allowing cellular DNA synthesis and replication to proceed. Discrepancies in the length of inhibition of cellular DNA synthesis and cell replication in our viruses deleted for ICP4, ICP22 and ICP27 compared with those described by Wu et al 6 may reflect differences in the experimental protocols used in evaluating mutant virus toxicities. In their experiments, viable cell numbers were measured following infection of a confluent monolayer whereas we infected cells in suspension and plated them at low density to measure cell viability based on colony formation. These different circumstances may affect the nuclear concentration of ICP0 or the rate at which viral DNA is lost from infected cells before and after cell division.
Although our experience with the triple mutant vectors described in this report demonstrates increased duration of transgene expression in neurons, expression in other cell types appears to be more limited. 19 Nevertheless, the reduced cytotoxicity of viruses deleted for ICP4, ICP22 and ICP27 may extend the utility of this HSV-1-based vector to applications where vector toxicity is less important and short-term gene expression is preferred. For example, we are currently evaluating this HSV vector background for its utility in simultaneously expressing multiple transgenes aimed at destruction of solid tumors in situ with the simultaneous stimulation of anticancer immunity. 31 For such applications, residual vector toxicity to dividing cells in the form of transient inhibition of DNA synthesis and cell division may be an advantage since infected tumor cells may experience arrested growth while at the same time vector toxicity is reduced allowing vigorous transgene expression. The expression of cytokines that provoke inflammatory or specific immune responses or enzymes that activate anticancer drugs should be adequate in this context. These vectors are also under examination for gene transfer to the peripheral and central nervous system. The reduced toxicity of these mutants should increase their safety for such applications and the level and duration of transgene expression in vivo from these mutant vector backbones remains to be determined.
Materials and methods
Construction of complementing cell lines and viral mutants
Complementing cell lines were constructed to propagate the multiply deleted recombinant viruses. The ICP27 complementing cell line N23 was produced by transfection of Vero cells with a single plasmid (pN23) which contains the ICP27 promoter and coding sequences (HSV-1 KOS genomic 113322-115743) and the SV40 early promoter driving neomycin phosphotransferase. The ICP4 and ICP27 complementing cell line 7B was produced by transfection of Vero cells with p4.12 which was produced by cloning the ICP4 promoter and coding sequences (HSV-1 KOS genomic 126749-131730) into pN23. 2 × 10 6 Vero cells were transfected with 5 or 10 g plasmid DNA using standard calcium phosphate technique. Twenty-four hours later the cells were trypsinized and seeded at 5 × 10 5 cells per 100 mm plate. Colonies were selected after 14 days of growth in media that contained 1 mg/ml neomycin (neomycin sulfate; Sigma Chemical, St Louis, MO, USA).
All virus constructs were created from virus backbones based on d120 (gift of N DeLuca, Dept of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine), a KOS strain mutant deleted for both copies of ICP4.
1 SHZ.1 was created by Cre-lox recombination of an HCMV-LacZ expression construct into the U L 23 thymidine kinase (HSV-TK) locus. 32 SHZ.2 was also created using the Cre-lox recombination method and is identical to SHZ.1 except for the addition of a cassette containing the HSV-1 ICP4 promoter driving HSV-TK into the native tk locus. S4TK is a d120 backbone mutant which contains the ICP4 immediate-early promoter substituted for the native TK promoter resulting in a deletion of the HSV-1 U L 24 gene. DHZ.1 and DHZ.2 were created by homologous recombination of an HCMV-LacZ expression cassette into the ICP22 and ICP47 immediate-early gene loci respectively of S4TK resulting in the following deletions: ICP22, genomic 133372-133465, and ICP47, 144332-145443. DHZ.3, THZ.1 and THZ.2 were created by a viral cross between DHZ.1 and 5dl1.2 (gift of P Schaffer). 33 Recombinants were screened for growth on E5 (ICP4 ) to test for the presence of deletion in either or both essential immediateearly genes ICP4 and ICP27. In these mutants the ICP22 deletion was monitored by X-gal staining for the lacZ expression cassette in ICP22. DHZ.4 was produced through a viral cross between SHZ.1 and 5dl1.2 as outlined above. THZ.3 was generated by viral cross between THZ.1 and ⌬Sma, 34 a virus deleted in the U L 41 virion host shut-off protein (a gift of GS Read, School of Biological Sciences, University of Missouri, USA). T0Z.1 was produced through a viral cross of S0Z.1 and T.1. T.1 is THZ.1 in which the lacZ gene was removed from the expression construct in ICP22 but which still contains the HCMV promoter and bovine growth hormone polyadenylation sequences in this locus. S0Z.1 was created via homologous recombination of an ICP0-LacZ expression construct into a SmaI-SmaI deletion, genomic 91606-92124, (identical deletion to ⌬Sma virus mentioned above) of UL41 in the background of S4TK. All marker transfer recombinations were produced via standard calcium phosphate transfection of 5 g viral DNA and 1 g linear recombination plasmid. Viral crosses were performed by co-infection of monolayers of 7B cells at a MOI of 5 for each virus followed by harvest at 18 h PI. All resultant viral mutants were purified by three rounds of limiting dilution and verified by Southern blot. Viral stocks were prepared and titered using 7B cells as described previously. 35 Evaluation of cytotoxicity Cytotoxicity of the mutant viruses for 9L rat gliosarcoma and Vero cells was evaluated after infection by measurement of thymidine incorporation, colony-forming ability and viable cell numbers. For thymidine incorporation experiments 4 × 10 4 cells were infected at a MOI ranging from 3 to 20 in 500 l of complete media (MEM, 10% fetal bovine serum) for 1 h at 37°C with agitation. Complete media (300 l) was added to each infection and the cells plated in 96-well plates (5 × 10 3 cells in 100 l per well). At times ranging from 24 to 60 h PI 1 Ci 3 H thymidine (Amersham, Arlington Heights, IL, USA) in 50 l fresh media was added per well. After incubation for 12 h cells were harvested using a Skatron (Sterling, VA, USA) cell harvester and 3 H thymidine incorporation was measured using a Becton Dickinson (San Jose, CA, USA) scintillation plate reader. For colony-forming assay, 9L cells were infected at a MOI of 3 or 10 and plated at a density of 250 cells per 10 cm plate in 10 ml media. Fourteen days after infection the plates were stained with 1% crystal violet (in 50:50 methanol:dH 2 0) and the number of colonies counted. Cell counts were performed after infection of Vero cells at a MOI of 3 or 10. At times ranging from 24 to 120 h PI the cells were trypsinized, resuspended, and after trypan blue staining, nonstained viable cells were counted.
The cytotoxicity of viral mutants was also determined for cortical neurons in culture. Cortex from 17-day-old rat embryos were dissociated with trypsin and plated on poly-l-lysine coated cover slips (for morphology) or plastic dishes (for biochemical studies) at 2 × 10 5 cells/ml in defined medium (neuroBasal medium supplemented with B-27), glutamax II, albumax, and nerve growth factor (NGF) 50 ng/ml (Gibco-BRL, Gaithersburg, MD, USA). Using this culture system we have found that cortical cells survive beyond 3 weeks in culture and that at 14 days 95% of the cells are nerve-specific enolase positive, neurofilament positive, a3 Na/K-ATPase positive, and GFAP negative. Cells were exposed to virus at a MOI of approximately 1 for 1 h followed by the addition of culture medium. At 7 days PI the cells on cover slips were fixed with 4% paraformaldehyde/0.25% glutaraldehyde and ␤-galactosidase detected by exposure to 1% X-gal reagent solution for 5-6 h. Cultured cells were exposed to Alamar blue (Alamar Biosciences, Westlake, OH, USA) (40 l/ml) overnight at 4°C and cell survival determined by quantitative fluorescence (530/590 nm excitation/emission). 9 For RNA analysis, the neurons were lysed in TRI reagent (Sigma Chemical), and RNA resuspended in 20 l distilled water. For RT-PCR reactions 5-10 l of each sample was used. In order to detect specific RNAs, extracts were treated with DNaseI (Worthington Biochemicals, Lakewood, NJ, USA, 1000 U) for 60 min at 37°C to destroy the DNA template. RNA templates were reverse transcribed in a final volume of 20 l, in RT-PCR assay buffer (4 l 5 × Superscript II Buffer (Gibco-BRL), 2 l of dNTPs (10 mm each), 0.1 mm DTT, 100 ng of oligo dT, 10 U of reverse transcriptase (Superscript II; Gibco-BRL), sterile distilled water to volume), at 37°C for 30 min to permit reverse transcription. The cDNA was split and 4-5 l aliquots were made up to 100 l using PCR reaction buffer and specific primers pairs as described: LAT 5Ј GAC-AGC-AAA-AAT-CCC-GTC-AG, LAT 3Ј ACG-AGG-GAA-AAC-AAT-AAG-GG, ICP0 5Ј GGA-CAG-CAC-GGA-CAC-GGA-A, ICP0 3Ј ATT-GCC-CGT-CCA-GAT-AAA-G, gB 5Ј ATT-CTC-CTC-CGA-CGC-CAT-ATC-CAC-CTT, gB 3Ј AGA-AAG-CCC-CCA-TTG-GCC-AGG-TAG-T, rpL32 5Ј GAA-CAC-AAA-ACA-GGC-ACA-C rpL32 3Ј GTG-AAG-CCC-AAG-ATC-GTC.
The cytotoxicity of viral mutants was also determined for dorsal root ganglia neurons in culture. Dorsal root ganglia (DRG) from 16-day-old rat embryo was dissociated by collagenase treatment followed by tritration and plated on rat tail collagen-coated eight-well slides in DMEM high glucose media supplemented with 2 × penicillin/streptomycin and nerve growth factor (NGF) 50 ng/ml. At 10 days after plating the cells were infected at MOIs of approximately 3 and 30 with SOZ.1 or TOZ.1 for 90 min followed by removal of the inoculum and addition of culture medium. At 1, 2, 4, 7, 14 and 21 d PI cultures were examined for: (1) ␤-galactosidase detection as described above; (2) cellular activity by the MTT method was performed by replacing the culture medium with 100 l media containing 0.5 mg/ml MTT and incubating at 37°C for 3 h followed by addition of 100 l 0.04 m HCl/isopropanol and an additional 1 h incubation to dissolve the crystallized MTT. Well contents were transferred to a 96-well plate and read at 574 nm; (3) apoptosis was visualized with a fluorescent TUNEL assay as described by the manufacturer (Boehringer Mannheim, Indianapolis, IN, USA); (4) immunohistochemistry was performed as described 6 using anti-ICP0 antibody at a 1:2000 dilution and FITC-anti rabbit secondary antibodies.
